ARC Clinical Research Featured in Community Impact
June 11, 2018
ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.
“These new medications have to be studied to prove they are effective,” said Dr. Anurekha Chadha, medical director of ARC Clinical Research. ARC has been among several sites nationally enrolling patients in the clinical trial. “It’s super-exciting for me… because this is really how you advance medicine,” Dr. Chadha commented.
Read: ARC Clinical Research featured in Community Impact